Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease
A pharmaceutical composition is provided, which comprises an aqeous solution containing a mixture of di- and tri-sodium salts of echinochrome in an amount of 0.90 to 1.10 g/ml (Histochrome). It meets the requirements that apply to injectable formulations. Administration of Histochrome reduces by 57%...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KOLTSOVA EVGENIA ALEXANDROVNA MISCHENKO NATALYA PETROVNA ARTJUKOV ALEXANDR ALEXEEVICH ELYAKOV GEORGY BORISOVICH MAXIMOV OLEG BORISOVICH FEDOREEV SERGEI ALEXANDROVICH KRASOVSKAYA NATALYA PETROVNA GLEBKO LJUTSIA IGNATIEVNA |
description | A pharmaceutical composition is provided, which comprises an aqeous solution containing a mixture of di- and tri-sodium salts of echinochrome in an amount of 0.90 to 1.10 g/ml (Histochrome). It meets the requirements that apply to injectable formulations. Administration of Histochrome reduces by 57% the necrosis zone in patients with acute myocardial infarction, restores the contractility of the left ventricle, reduces the incidence of reperfusion-induced ventricular arrhythmias and exerts an antiarrhythmogenic effect. Histochrome suppresses the aggregation of erythrocytes and thrombocytes, produces a beneficial effect on the clinical course of the disease, reduces the incidence of complications and lethal outcomes in cases of acute myocardial infarction. It is well tolerated by patients. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US6410601B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US6410601B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US6410601B23</originalsourceid><addsrcrecordid>eNqNizEKwkAQRdNYiHqHuYCQqOQAipJeLSUMkx92INkNO5PC2xvQA1g9eLy3Ll6NmicJOY0gjh2pG3lA5gmzq9BsII3EMjtofCfh3CkPi-s5i2uK380kYFz6AM5OnRrYsC1WPQ-G3Y-bgm7Xx6XZY0otbGJBhLfPe32qyrqszofjH8kHoBI8Eg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease</title><source>esp@cenet</source><creator>KOLTSOVA EVGENIA ALEXANDROVNA ; MISCHENKO NATALYA PETROVNA ; ARTJUKOV ALEXANDR ALEXEEVICH ; ELYAKOV GEORGY BORISOVICH ; MAXIMOV OLEG BORISOVICH ; FEDOREEV SERGEI ALEXANDROVICH ; KRASOVSKAYA NATALYA PETROVNA ; GLEBKO LJUTSIA IGNATIEVNA</creator><creatorcontrib>KOLTSOVA EVGENIA ALEXANDROVNA ; MISCHENKO NATALYA PETROVNA ; ARTJUKOV ALEXANDR ALEXEEVICH ; ELYAKOV GEORGY BORISOVICH ; MAXIMOV OLEG BORISOVICH ; FEDOREEV SERGEI ALEXANDROVICH ; KRASOVSKAYA NATALYA PETROVNA ; GLEBKO LJUTSIA IGNATIEVNA</creatorcontrib><description>A pharmaceutical composition is provided, which comprises an aqeous solution containing a mixture of di- and tri-sodium salts of echinochrome in an amount of 0.90 to 1.10 g/ml (Histochrome). It meets the requirements that apply to injectable formulations. Administration of Histochrome reduces by 57% the necrosis zone in patients with acute myocardial infarction, restores the contractility of the left ventricle, reduces the incidence of reperfusion-induced ventricular arrhythmias and exerts an antiarrhythmogenic effect. Histochrome suppresses the aggregation of erythrocytes and thrombocytes, produces a beneficial effect on the clinical course of the disease, reduces the incidence of complications and lethal outcomes in cases of acute myocardial infarction. It is well tolerated by patients.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020625&DB=EPODOC&CC=US&NR=6410601B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020625&DB=EPODOC&CC=US&NR=6410601B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOLTSOVA EVGENIA ALEXANDROVNA</creatorcontrib><creatorcontrib>MISCHENKO NATALYA PETROVNA</creatorcontrib><creatorcontrib>ARTJUKOV ALEXANDR ALEXEEVICH</creatorcontrib><creatorcontrib>ELYAKOV GEORGY BORISOVICH</creatorcontrib><creatorcontrib>MAXIMOV OLEG BORISOVICH</creatorcontrib><creatorcontrib>FEDOREEV SERGEI ALEXANDROVICH</creatorcontrib><creatorcontrib>KRASOVSKAYA NATALYA PETROVNA</creatorcontrib><creatorcontrib>GLEBKO LJUTSIA IGNATIEVNA</creatorcontrib><title>Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease</title><description>A pharmaceutical composition is provided, which comprises an aqeous solution containing a mixture of di- and tri-sodium salts of echinochrome in an amount of 0.90 to 1.10 g/ml (Histochrome). It meets the requirements that apply to injectable formulations. Administration of Histochrome reduces by 57% the necrosis zone in patients with acute myocardial infarction, restores the contractility of the left ventricle, reduces the incidence of reperfusion-induced ventricular arrhythmias and exerts an antiarrhythmogenic effect. Histochrome suppresses the aggregation of erythrocytes and thrombocytes, produces a beneficial effect on the clinical course of the disease, reduces the incidence of complications and lethal outcomes in cases of acute myocardial infarction. It is well tolerated by patients.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEKwkAQRdNYiHqHuYCQqOQAipJeLSUMkx92INkNO5PC2xvQA1g9eLy3Ll6NmicJOY0gjh2pG3lA5gmzq9BsII3EMjtofCfh3CkPi-s5i2uK380kYFz6AM5OnRrYsC1WPQ-G3Y-bgm7Xx6XZY0otbGJBhLfPe32qyrqszofjH8kHoBI8Eg</recordid><startdate>20020625</startdate><enddate>20020625</enddate><creator>KOLTSOVA EVGENIA ALEXANDROVNA</creator><creator>MISCHENKO NATALYA PETROVNA</creator><creator>ARTJUKOV ALEXANDR ALEXEEVICH</creator><creator>ELYAKOV GEORGY BORISOVICH</creator><creator>MAXIMOV OLEG BORISOVICH</creator><creator>FEDOREEV SERGEI ALEXANDROVICH</creator><creator>KRASOVSKAYA NATALYA PETROVNA</creator><creator>GLEBKO LJUTSIA IGNATIEVNA</creator><scope>EVB</scope></search><sort><creationdate>20020625</creationdate><title>Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease</title><author>KOLTSOVA EVGENIA ALEXANDROVNA ; MISCHENKO NATALYA PETROVNA ; ARTJUKOV ALEXANDR ALEXEEVICH ; ELYAKOV GEORGY BORISOVICH ; MAXIMOV OLEG BORISOVICH ; FEDOREEV SERGEI ALEXANDROVICH ; KRASOVSKAYA NATALYA PETROVNA ; GLEBKO LJUTSIA IGNATIEVNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US6410601B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOLTSOVA EVGENIA ALEXANDROVNA</creatorcontrib><creatorcontrib>MISCHENKO NATALYA PETROVNA</creatorcontrib><creatorcontrib>ARTJUKOV ALEXANDR ALEXEEVICH</creatorcontrib><creatorcontrib>ELYAKOV GEORGY BORISOVICH</creatorcontrib><creatorcontrib>MAXIMOV OLEG BORISOVICH</creatorcontrib><creatorcontrib>FEDOREEV SERGEI ALEXANDROVICH</creatorcontrib><creatorcontrib>KRASOVSKAYA NATALYA PETROVNA</creatorcontrib><creatorcontrib>GLEBKO LJUTSIA IGNATIEVNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOLTSOVA EVGENIA ALEXANDROVNA</au><au>MISCHENKO NATALYA PETROVNA</au><au>ARTJUKOV ALEXANDR ALEXEEVICH</au><au>ELYAKOV GEORGY BORISOVICH</au><au>MAXIMOV OLEG BORISOVICH</au><au>FEDOREEV SERGEI ALEXANDROVICH</au><au>KRASOVSKAYA NATALYA PETROVNA</au><au>GLEBKO LJUTSIA IGNATIEVNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease</title><date>2002-06-25</date><risdate>2002</risdate><abstract>A pharmaceutical composition is provided, which comprises an aqeous solution containing a mixture of di- and tri-sodium salts of echinochrome in an amount of 0.90 to 1.10 g/ml (Histochrome). It meets the requirements that apply to injectable formulations. Administration of Histochrome reduces by 57% the necrosis zone in patients with acute myocardial infarction, restores the contractility of the left ventricle, reduces the incidence of reperfusion-induced ventricular arrhythmias and exerts an antiarrhythmogenic effect. Histochrome suppresses the aggregation of erythrocytes and thrombocytes, produces a beneficial effect on the clinical course of the disease, reduces the incidence of complications and lethal outcomes in cases of acute myocardial infarction. It is well tolerated by patients.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US6410601B2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T12%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOLTSOVA%20EVGENIA%20ALEXANDROVNA&rft.date=2002-06-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS6410601B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |